MedPath
HSA Approval

WELUSIL TABLET

SIN05336P

WELUSIL TABLET

WELUSIL TABLET

January 12, 1991

TIENTSIN DA-CHONG TRADING

TIENTSIN DA-CHONG TRADING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTIENTSIN DA-CHONG TRADING
Licence HolderTIENTSIN DA-CHONG TRADING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AD01

ordinary salt combinations

Manufacturer Information

TIENTSIN DA-CHONG TRADING

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

DRIED ALUMINIUM HYDROXIDE GEL

250 mg

Aluminum hydroxide

MAGNESIUM TRISILICATE

250mg

Magnesium trisilicate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

WELUSIL TABLET - HSA Approval | MedPath